Skip to content
Screener

Establishment Labs ESTA Total Liabilities & Equity

Total Liabilities & Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$201.06B+4.0%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
IAR
Integra LifeSciencesIART
$3.56B-2.8%
Artivion logo
ArtivionAORT
$1.07B+27.9%
Globus Medical logo
Globus MedicalGMED
$5.49B+10.6%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$873.02M+4.3%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemJune 30,2026December 31,2025
Shareholders’ equity:
Common shares — zero par value, unlimited amount authorized; 30,201,123 and 29,713,024 shares issued at June 30, 2026 and December 31, 2025, respectively; 29,793,053 and 29,304,954 shares outstanding at June 30, 2026 and December 31, 2025, respectively450,587433,378
Additional paid-in-capital92,60387,624
Treasury shares, at cost, 408,070 shares held at June 30, 2026 and December 31, 2025(2,854)(2,854)
Accumulated deficit(520,886)(495,756)
Accumulated other comprehensive income2,1571,155
Total shareholders’ equity21,60723,547
Total liabilities and shareholders’ equity$351,926$357,167

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's total liabilities & equity?
Establishment Labs (ESTA) reported total liabilities & equity of $351.93M in Q2 2026.
How has Establishment Labs's total liabilities & equity changed year-over-year?
Establishment Labs's total liabilities & equity increased by 6.8% year-over-year, from $329.67M to $351.93M.
What is the long-term trend for Establishment Labs's total liabilities & equity?
Over 5 years (2020 to 2025), Establishment Labs's total liabilities & equity has grown at a 18.0% compound annual growth rate (CAGR), from $156.39M to $357.17M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Establishment Labs's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude